117 related articles for article (PubMed ID: 9046832)
1. [Epstein-Barr virus penetration mechanism to T lymphoblastoid cell lines].
Uno M
Nihon Rinsho; 1997 Feb; 55(2):404-8. PubMed ID: 9046832
[TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
3. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.
Katsumura KR; Maruo S; Takada K
J Med Virol; 2012 Mar; 84(3):504-10. PubMed ID: 22246839
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
Guan M; Romano G; Henderson EE
Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585
[TBL] [Abstract][Full Text] [Related]
5. [Isolation and characterization of Epstein-Barr virus-infected clones of a human T-lymphoblastoid cell line].
Fujiwara S; Nakamura H; Iwakiri D; Ono Y
Nihon Rinsho; 1997 Feb; 55(2):416-23. PubMed ID: 9046834
[TBL] [Abstract][Full Text] [Related]
6. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
7. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
Van Kuyk R; Mosier DE
Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction.
Yang L; Aozasa K; Oshimi K; Takada K
Cancer Res; 2004 Aug; 64(15):5332-7. PubMed ID: 15289339
[TBL] [Abstract][Full Text] [Related]
9. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas.
Brink AA; ten Berge RL; van den Brule AJ; Willemze R; Chott A; Meijer CJ
J Pathol; 2000 Aug; 191(4):400-6. PubMed ID: 10918215
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
12. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
[TBL] [Abstract][Full Text] [Related]
14. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.
Baran-Marszak F; Laguillier C; Youlyouz I; Feuillard J; Mariette X; Fagard R; Raphaël M
Cytokine; 2006 Mar; 33(6):337-45. PubMed ID: 16713282
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
16. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
17. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
18. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
19. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
20. EBV infection of T cells: potential role in malignant transformation.
Kelleher CA; Dreyfus DH; Jones JF; Gelfand EW
Semin Cancer Biol; 1996 Aug; 7(4):197-207. PubMed ID: 8946604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
